The UCLA Center for Human Nutrition
The UCLA Center for Human Nutrition is a leader in both research and clinical care settings with the goal of advancing knowledge and treatment in variety of nutrition-related health issues including obesity, metabolic disease, cardiovascular disease and cancer. By understanding the effects of nutrients on the human body through research, we aim to translate this to the clinical practice in the care of our patients. From 1992 to 2006 the UCLA Center for Human Nutrition was part of the National Institutes of Health's Clinical Nutrition Research Unit that investigated the links between cancer and nutrition. Additionally, the foundational research conducted by the Center led to the development of our UCLA Medical Weight Management Program (formerly known as RFO) which was described by the US News and World Report as "one of the most thorough weight management programs in the country."
UCLA Medical Weight Management Program
UCLA Medical Weight Management Program (formerly known as RFO) is a medically-supervised multidisciplinary program first established in 1976. It was one of the first university programs to research very low-calorie diets (VLCDs) in the treatment of obesity. Our program features a multidisciplinary team of experienced physicians, nurse practitioners, registered dietitians, clinical psychologist and therapists to implement dietary, physical activity and behavioral lifestyle changes and promote healthy weight management long-term.
UCLA Clinical Nutrition Clinic
The Clinical Nutrition Clinic features physician nutrition specialists who see patients for individual consultation with a variety of nutritional conditions including weight management, cancer, gastrointestinal disorders to name a few.
Center for Human Nutrition Research
The UCLA Center for Human Nutrition conducts cutting-edge biomedical and health-related research studies that include both interventional and observational studies. Our clinical studies are sponsored/funded by National Institute of Health (NIH), pharmaceutical companies, and/or non-profit medical institutions/organizations.